Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001384243-26-000002

Director sold 15,960 shares at an average $45.22 ($721,635)

  • Director acquired 15,960 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Quart Barry D Director 2026-02-02 Option exercise 10b5-1 +830 $15.47 $12,840 13,376 D
Quart Barry D Director 2026-02-02 Sale 10b5-1 −830 $45.00 $37,350 12,546 D
Quart Barry D Director 2026-02-03 Option exercise 10b5-1 +12,528 $15.47 $193,808 25,074 D
Quart Barry D Director 2026-02-03 Sale 10b5-1 −12,528 $45.27 $567,143 12,546 D
Quart Barry D Director 2026-02-04 Option exercise 10b5-1 +2,602 $15.47 $40,253 15,148 D
Quart Barry D Director 2026-02-04 Sale 10b5-1 −2,602 $45.02 $117,142 12,546 D
Derivatives
Quart Barry D Director 2026-02-02 Option exercise · Share Option 10b5-1 −830 17,930 D
Quart Barry D Director 2026-02-03 Option exercise · Share Option 10b5-1 −12,528 5,402 D
Quart Barry D Director 2026-02-04 Option exercise · Share Option 10b5-1 −2,602 2,800 D
Open-market sales · 15,960 sh · avg $45.22 · $721,635
Loading xslF345X05/form4-02042026_110219.xml…